Literature DB >> 7363565

Indium (111In)-labelled human platelets: optimal method.

R J Hawker, L M Hawker, A R Wilkinson.   

Abstract

1. A detailed laboratory method is described for the labelling of human platelets with [111In]indium oxine. The 45 min method is simple, requires on 26 ml of blood and is suitable for routine clinical use. 2. After the labelling and resuspension of the platelets in plasma, aggregation responses to both adenosine diphosphate and collagen were similar to those of normal platelet-rich plasma. Less than 5% of the [111In]indium oxine was released by secretory function of platelets. 3. Labelling efficiencies of 90.1 +/- 4.29% (n = 28) were achieved in 60 s by normal concentrations of plasma-free platelet suspensions. 4. Platelet survival in vivo in healthy volunteer subjects follows a linear function with a survival time of 8.44 +/- 0.18 days.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7363565     DOI: 10.1042/cs0580243

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  20 in total

1.  Detection of arterial thrombosis after laser angioplasty by platelet scintigraphy.

Authors:  S R Mohan; R J Hawker; A P Wolinski; R P Grimley
Journal:  Eur J Nucl Med       Date:  1990

2.  An improved method for the quantification of the in vivo kinetics of a representative population of 111In-labelled human platelets.

Authors:  P Wessels; A D Heyns; H Pieters; M G Lötter; P N Badenhorst
Journal:  Eur J Nucl Med       Date:  1985

3.  A study of platelet-relevant parameters in patients with diabetic microangiopathy.

Authors:  M Porta; A M Peters; S A Cousins; E Cagliero; M L FitzPatrick; E M Kohner
Journal:  Diabetologia       Date:  1983-07       Impact factor: 10.122

4.  Diagnosis of aortic aneurysm using autologous platelets labelled with indium-111.

Authors:  A Fenech; J K Hussey; F W Smith; P P Dendy; B Bennett; A S Douglas
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-04

5.  Degradation of sulfated proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase.

Authors:  J Yahalom; A Eldor; Z Fuks; I Vlodavsky
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

6.  A simple and safe technique for sterile autologous platelet labelling using "Monovette" vials.

Authors:  H Sinzinger; H Kolbe; E Strobl-Jäger; R Höfer
Journal:  Eur J Nucl Med       Date:  1984

7.  The effects of amrinone on platelet count, survival and function in patients with congestive cardiac failure.

Authors:  P T Wilmshurst; S F Al-Hasani; M J Semple; A S Hamblin; P G Kioy; G F Lucas; G F Savidge; M M Webb-Peploe
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

8.  Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disorders.

Authors:  H Ludwig; W Linkesch; H Gisslinger; E Fritz; H Sinzinger; T Radaszkiewicz; A Chott; R Flener; M Micksche
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

9.  Loss of 5-hydroxytryptamine from mammalian circulating labelled platelets.

Authors:  E E Osim; J H Wyllie
Journal:  J Physiol       Date:  1983-07       Impact factor: 5.182

10.  Thromboembolism in inflammatory bowel disease: role of platelets.

Authors:  M J Webberley; M T Hart; V Melikian
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.